PODD Related New Coverage
-
Raymond James Starts Insulet Corporation (PODD) at Outperform
-
Northland Securities Starts Insulet Corporation (PODD) at Outperform
-
CL King Starts Insulet Corporation (PODD) at Sell
-
Avondale Partners Starts Insulet Corporation (PODD) at Market Outperform
-
Piper Jaffray Starts Insulet Corporation (PODD) at Neutral
-
Brean Murray Carret & Co. Starts Insulet Corporation (PODD) at Buy; Attractive Growth Story With Key Approval Near Term
-
CL King Starts Insulet (PODD) at Neutral
-
Feltl & Co Starts Insulet Corporation (PODD) at Buy
-
Wunderlich Securities Starts Insulet Corporation (PODD) at Buy
-
Oppenheimer Starts Insulet (PODD), Thoratec (THOR) at Outperform, DexCom (DXCM), HeartWare (HTWR) at Perform
-
Jefferies Starts Insulet Corporation (PODD) at Buy, Price Target $19
-
Weeden Starts STJ, THOR, DXCM, PODD at Buy, MNKD, ISRG, MDT, BSX at Hold
-
JMP Securities Initiates/Resumes Coverage Medical Instruments & Supplies Stocks (ALGN, PODD, NUVA)
-
Capstone Initiates Coverage on Insulet (PODD) with a Buy
-
JMP Securities Initiates Coverage on Insulet (PODD) with a Market Outperform
-
Rodman & Renshaw Starts NXTM, THOR, MEND, SPNC at Outperform, EW, SRDX at Underperform
-
Boenning & Scattergood Initiates Coverage on Insulet (PODD) with an Outperform
-
Soleil Starts Insulet (PODD) at Buy, DexCom (DXCM) at Hold
-
JMP Securities Starts Insulet (PODD) at Outperform
-
Thomas Weisel Starts Insulet Corporation (PODD) at Overweight
-
Canaccord Adams Starts Insulet (PODD) at Buy
-
BWS Financial Starts Insulet Corporation (PODD) at Buy
-
Merrill Lynch Starts Insulet (PODD) at Buy
-
JP Morgan Starts Insulet (PODD) at Overweight
Back to PODD Stock Lookup
